Ultraviolet (UV) radiation promotes skin cancer through multiple mechanisms, which can be secondary to inflammation, oxidative stress, and DNA damage. UV-induced DNA mutations may arise from disrepair of cyclobutane pyrimidine dimers (CPD) or 8-oxoguanine (8-OG). We investigated whether the anti-inflammatory activities of aspirin (ASA) could protect against UV-induced DNA damage and skin cancer in mouse models. Skin from adult C57BL/6 mice receiving 0.4 mg ASA daily by gavage had reduced inflammation (CD3+ T-lymphocytes, CD272+ lymphocytes/NK cells, Ly6G+ neutrophils, F4/80+ macrophages), fewer sunburn cells, and lower 8-OG levels than skin from control animals (gavaged with only water) 48 h after acute UVB exposure (600 J/m2).